Brief: Elevation Oncology Reports First Quarter 2022 Financial Results
05/05/2022 12:34
May 5 (Reuters) - Elevation Oncology Inc ELEV.O :
* ELEVATION ONCOLOGY REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT COMPANY PROGRESS
* QTRLY NET LOSS PER SHARE $0.74
* Q1 EARNINGS PER SHARE VIEW $-0.50 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn1zvBhpa
Further company coverage: ELEV.O
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing